Clinical Trials Logo

Prostatic Neoplasm clinical trials

View clinical trials related to Prostatic Neoplasm.

Filter by:

NCT ID: NCT00001266 Completed - Prostatic Neoplasm Clinical Trials

A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma

Start date: October 1990
Phase: Phase 2
Study type: Interventional

One current hypothesis as to what limits duration of initial hormone response is the rapid emergence of hormone resistant prostate carcinoma cells. Suramin has shown effectiveness as a treatment for hormonally refractory prostate carcinoma. Survival was less in patients with high rather than low circulating androgen levels. Thus, suramin might slow the emergence of hormone refractory tumor cells while combined androgen ablation may maximize the effectiveness of suramin. In this trial, we will pilot this concept.